why choose us

First received: March 03, 2023

Clinical Trial: Single Dose Study of MK-2060 to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Older Japanese Participants on Dialysis (MK-2060-012)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: End-Stage Renal Disease (ESRD)

Study Type: INTERVENTIONAL


Official Title: A Single-dose Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-2060 in Japanese Older Participants With End-stage Renal Disease on Dialysis.

Brief Summary: The purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of MK-2060 after a single dose intravenous (IV) administration in Japanese older participants with end stage renal disease (ESRD) on dialysis.There is no primary hypothesis for this study.

Read more